Natural IgG autoantibodies are abundant and ubiquitous in human sera, and their number is influenced by age, gender, and disease EP Nagele, M Han, NK Acharya, C DeMarshall, MC Kosciuk, RG Nagele PloS one 8 (4), e60726, 2013 | 340 | 2013 |
Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera E Nagele, M Han, C DeMarshall, B Belinka, R Nagele PloS one 6 (8), e23112, 2011 | 201 | 2011 |
Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood–brain barrier breakdown EC Levin, NK Acharya, M Han, SB Zavareh, JC Sedeyn, V Venkataraman, ... Brain research 1345, 221-232, 2010 | 150 | 2010 |
Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib NK Acharya, EC Levin, PM Clifford, M Han, R Tourtellotte, D Chamberlain, ... Journal of Alzheimer's Disease 35 (1), 179-198, 2013 | 144 | 2013 |
Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human sera M Han, E Nagele, C DeMarshall, N Acharya, R Nagele PloS one 7 (2), e32383, 2012 | 132 | 2012 |
Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease NK Acharya, EP Nagele, M Han, NJ Coretti, C DeMarshall, MC Kosciuk, ... Journal of autoimmunity 38 (4), 369-380, 2012 | 117 | 2012 |
Detection of Alzheimer's disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers CA DeMarshall, EP Nagele, A Sarkar, NK Acharya, G Godsey, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 3, 51-62, 2016 | 88 | 2016 |
Brain-reactive autoantibodies prevalent in human sera increase intraneuronal amyloid-β 1-42 deposition RG Nagele, PM Clifford, G Siu, EC Levin, NK Acharya, M Han, ... Journal of Alzheimer's Disease 25 (4), 605-622, 2011 | 87 | 2011 |
Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration JA Ochoa-Alvarez, H Krishnan, Y Shen, NK Acharya, M Han, DE McNulty, ... Public Library of Science 7 (7), e41845, 2012 | 79 | 2012 |
Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson’s disease CA DeMarshall, M Han, EP Nagele, A Sarkar, NK Acharya, G Godsey, ... Immunology letters 168 (1), 80-88, 2015 | 46 | 2015 |
Autoantibodies: double agents in human disease NK Acharya, EP Nagele, M Han, RG Nagele Science Translational Medicine 5 (186), 186fs19-186fs19, 2013 | 9 | 2013 |
Podoplanin (PDPN): novel biomarker and chemotherapeutic target H Krishnan, J Ochoa-alvarez, Y Shen, E Nevel, D Kephart, A Nguyen, ... Cancer Research 75 (15_Supplement), 4375-4375, 2015 | 2 | 2015 |
Blood-brain barrier (Bbb) breakdown and brain-reactive autoantibodies as a trigger for Cns diseases RG Nagele, NK Acharya, M Han, C DeMarshall, MC Kosciuk, EP Nagele Gerontologist 52, 453-453, 2012 | 1 | 2012 |
P4‐317: Detection of Alzheimer’S Disease at Mild Cognitive Impairment and Disease Staging Using Autoantibodies as Blood‐Based Biomarkers C DeMarshall, A Sarkar, M Han, E Nagele, N Acharya, U Thayasivam, ... Alzheimer's & Dementia 12, P1155-P1156, 2016 | | 2016 |
DETECTION OF ALZHEIMER’S DISEASE AT MILD COGNITIVE IMPAIRMENT AND DISEASE STAGING USING AUTOANTIBODIES AS BLOOD-BASED BIOMARKERS C DeMarshall, A Sarkar, M Han, E Nagele, N Acharya, U Thayasivam, ... Alzheimer's & Dementia 7 (12), P1155-P1156, 2016 | | 2016 |
P4‐235: Diagnosis of early‐stage Alzheimer's disease at mild cognitive impairment using autoantibodies as blood‐based biomarkers C DeMarshall, A Sarkar, M Han, E Nagele, N Acharya, U Thayasivam, ... Alzheimer's & Dementia 11 (7S_Part_19), P870-P870, 2015 | | 2015 |
Autoantibodies as Blood-based, Multi-Disease Biomarkers: Diagnosis of Early-Stage Alzheimer's and Parkinson's Diseases C DeMarshall, A Sarkar, M Han, EP Nagele, NK Acharya, U Thayasivam, ... MOLECULAR BIOLOGY OF THE CELL 26, 2015 | | 2015 |
Podoplanin (PDPN) presents a unique target to inhibit tumor cell growth and motility. H Krishnan, JA Ochoa-Alvarez, Y Shen, EM Nevel, DJ Kephart, M Han, ... MOLECULAR BIOLOGY OF THE CELL 25, 2014 | | 2014 |
Novel Ways to Target Podoplanin to Combat Cancer H Krishnan, JA Ochoa-Alvarez, Y Shen, E Nevel, M Han, NK Acharya, ... MOLECULAR BIOLOGY OF THE CELL 24, 2013 | | 2013 |
Diagnosis of Parkinson’s Disease Based on Disease-Specific Autoantibody Profiles in Human M Han, E Nagele, C DeMarshall, N Acharya, R Nagele | | 2012 |